Newsroom

Press releases

24.02.2026

DORDA appoints new Management Committee to mark its 50th anniversary

The business law firm DORDA is starting its 50th anniversary year with a clear agenda for the future: the partnership has elected a new Management Committee that combines experience, innovative strength, and clear future focus.

12.02.2026

DORDA impresses once again in Chambers Global Guide 2026

The results of the Chambers Global Guide 2026 once again confirm DORDA's leading position.

12.01.2026

MLI Media Law International Awards 2025: DORDA named Law Firm of the Year 2025

The media law team at DORDA celebrated another significant success at the end of 2025, when it was awarded Law Firm of the Year 2025 in recognition of its outstanding expertise.

06.08.2025

DRS Investment acquires a majority stake in AURENA with support by DORDA

The DORDA Digital Industries Group advised German investor DRS Investment SE on the successful acquisition of a majority stake in Aurena GmbH, a leading Austria

News Blog

27.02.2026

Regulatory Boundaries in the Age of Health AI

AI chatbots have become a first access point for many users seeking health and symptom information. A recent New York Times article ("They Asked an A.I. Chatbot Questions.

26.02.2026

Ist Ihr AI Chatbot heimlich ein Medizinprodukt?

AI‑Chatbots werden für viele Nutzerinnen und Nutzer zu einem ersten Zugangspunkt für Gesundheits‑ und Symptominformationen. Ein aktueller Beitrag der New York Times (They Asked an A.I. Chatbot Questions. The Answers Sent Them Spiraling.

26.02.2026

Human Medicines in 2025: What the EMA’s Data Reveals About the State of Innovation in Europe

Innovation in the life science rarely unfolds in dramatic bursts. More often, it advances through a steady accumulation of regulatory decisions, scientific evidence and coordinated policymaking.

26.02.2026

From Code to Cure: How Regulators Are Bringing Structure to AI in Medicine

Artificial intelligence has rapidly moved from a promising experimental tool to a foundational element across the medicines lifecycle.

Podcasts

ukraine_folge_website.png
Episode 96

05.02.2026

Wiederaufbau Ukraine: Chancen für Österreichs Wirtschaft

Der Wiederaufbau der Ukraine wird eine der zentralen wirtschaftlichen und gesellschaftlichen Aufgaben der kommenden Jahre sein.

fth_x_kulmer_equal_pay_de.png
Episode 95

29.01.2026

Europas Weg zu Equal Pay: Transparente Gehälter, klare Pflichten

Die EU-Entgelttransparenzrichtlinie wird Unternehmen in den kommenden Jahren intensiv beschäftigen, insbesondere Personalverantwortliche, Rechtsabteilungen und Führungskräfte.

fth_x_kulmer_equal_pay_e.png
Episode 94

29.01.2026

Closing the Gender Pay Gap: What the EU Directive Means for Companies

In the coming years, the EU Pay Transparency Directive will significantly shape how companies operate, particularly for HR professionals, legal departments, and business leaders.

Folge_Geldwäsche.png
Episode 93

20.11.2025

Schmutziges Geld - Geldwäscherei in Österreich

In dieser Folge sprechen Katrin Repic (Counsel bei DORDA im Bereich Banking & Regulatory) und Philipp Stadtegger (DORDA-Rechtsanwalt im Bereich Dispute Resolution und Co-Head für White-Collar Crime) über das komplexe Thema Geldwäscherei.

Press contact

As a business law firm, we are aware of our economic and social responsibilities, which is why an open exchange with the public is important to us.  
In addition to current press releases we offer you important information about DORDA.
If you have any questions or require further information, please direct your inquiry to:

Alexandra Mader
Head of Corporate Communication

+43-1-533 47 95-3973
alexandra.mader@dorda.at